PharmaEssentia
The Medical Science Liaison serves as a key member of the Medical Affairs Team, facilitating relationships with healthcare professionals and the scientific community to exchange medical information regarding myeloproliferative neoplasms. The role involves providing high-quality medical support, leading medical education, and managing studies aligned with medical and commercial objectives. This position requires maintaining scientific expertise in hematology and oncology while ensuring compliance with regulatory guidelines.
Headquarters
Burlington, Massachusetts, United States
Company Size
201-500 employees
Founded
2003
PharmaEssentia is a Taiwan-based global biopharmaceutical company focused on researching, developing, and commercializing best-in-class therapies for blood disorders and other serious diseases. Its portfolio includes Ropeginterferon alfa‑2b (marketed as Besremi) for polycythemia vera and other myeloproliferative neoplasms, and the company conducts clinical trials, medical affairs, and manufacturing activities worldwide. PharmaEssentia provides resources for patients and healthcare professionals and emphasizes innovation in protein engineering and biologics production. It aims to bring effective, scientifically driven treatments to patients through robust R&D and global partnerships.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for PharmaEssentia.
3% above the average for this role
Pipeline Medical Science Liaison (MSL)
AbbVie
Medical Science Liaison
Amplity Health
Medical Science Liaison, Singapore, Hematology
Amplity Health
Medical Science Liaison (MSL)/Sr. MSL - Carolinas
Genmab
Medical Science Liaison (Baltimore)
ADC Therapeutics
Medical Science Liaison (New England)
ADC Therapeutics